期刊
INTERNATIONAL REVIEWS OF IMMUNOLOGY
卷 30, 期 5-6, 页码 294-311出版社
TAYLOR & FRANCIS INC
DOI: 10.3109/08830185.2011.595855
关键词
Chimeric Antigen Receptors; Cancer; Gene Therapy; Immunotherapy
类别
资金
- Brazilian Ministry of Health
- CAPES
- Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq)
- Instituto do Milenio de Terapia Genica - CNPq
- Instituto Nacional de Cancer
- Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
The concept of chimeric antigen receptors (CARs) as molecules able to redirect T lymphocytes toward tumor cells is currently being exploited in the field of cancer immunotherapy. Despite promising preliminary results, some clinical trials evidenced limitations for this technology that must be overcome for more extensive application of CARs in tumor immunotherapy. We describe here the fundaments of these molecules in terms of structure, function, possible targets and preclinical and clinical applications. We also discuss strategies that can potentially overcome the limitations seen so far, paving the road to a wider application of this exciting new technology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据